Extended-spectrum β-Lactamase-Producing Enterobacteriaceae Causing Nosocomial Infections in Mexico. A Retrospective and Multicenter Study

Archives of Medical Research

Volumn 42, Issue 2, 2011, Pages 156-162

  Silva Sanchez, Jesus ^a   Garza Ramos, Jesus Ulises ^a   Reyna Flores, Fernando ^a   Sánchez Perez, Alejandro ^a   Rojas Moreno, Teresa ^a   Andrade Almaraz, Veronica ^a   Pastrana, Josefina ^a   Castro Romero, Julieta Ivone ^a   Vinuesa, Pablo ^b   Barrios, Humberto ^a   Cervantes, Carlos ^c  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b INSTITUTO DE CIENCIAS FÍSICAS   (Mexico)

^c UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

Author keywords

Enterobacter cloacae; Escherichia coli; Extended spectrum lactamase; Klebsiella pneumoniae; Nosocomial infection

Indexed keywords

AMIKACIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; BIOASSAY; CONTROLLED STUDY; DISK DIFFUSION; ENDEMIC SPECIES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENE AMPLIFICATION; HOSPITAL INFECTION; KLEBSIELLA PNEUMONIAE; MEXICO; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORGANISMS BY GEOGRAPHICAL DISTRIBUTION; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; SPECIES DIFFERENCE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFOTAXIME; CONGRESSES AS TOPIC; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; ISOELECTRIC POINT; MEXICO; MICROBIAL SENSITIVITY TESTS; R FACTORS; RETROSPECTIVE STUDIES;

EID: 79955728984     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.02.004     Document Type: Article

References (29)

1. Lautenbach E., Patel J.B., Bilker W.B., et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001, 32:1162-1171.
2. Peleg A.Y., Hooper D.C. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 2010, 362:1804-1813.
3. Tzoubelekis L., Bonomo R. SHV-type beta-lactamases. Curr Pharm Des 1999, 5:847-864.
4. Bradford P.A. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001, 14:933-951.
5. Davis J. Inactivation of antibiotics and the dissemination of resistant genes. Science 1994, 264:375-382.
6. Gales A.C., Sader H.S., Jones R.N. Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000). Diagn Microbiol Infect Dis 2002, 44:289-299.
7. Rocha-Gracia R., Ruiz E., Romero-Romero S., et al. Detection of the plasmid-borne quinolone resistance determinant qepA1 in a CTX-M-15-producing Escherichia coli strain from Mexico. J Antimicrob Chemother 2010, 65:169-171.
8. Alcantar-Curiel D., Tinoco J.C., Gayosso C., et al. Nosocomial bacteremia and urinary tract infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes. Clin Infect Dis 2004, 38:1067-1074.
9. Garza-Ramos U., Martinez-Romero E., Silva-Sanchez J. SHV-type extended-spectrum β-lactamase (ESBL) are encoded in related plasmids from enterobacteria clinical isolates from Mexico. Salud Publica Mex 2007, 49:415-421.
10. Miranda G., Castro N., Leanos B., et al. Clonal and horizontal dissemination of Klebsiella pneumoniae expressing SHV-5 extended-spectrum β-lactamase in a Mexican pediatric hospital. J Clin Microbiol 2004, 42:30-35.
11. Silva J., Aguilar C., Ayala G., et al. TLA-1: a new plasmid-mediated extended-spectrum β-lactamase from Escherichia coli. Antimicrob Agents Chemother 2000, 44:997-1003.
12. Silva J., Gatica R., Aguilar C., et al. Outbreak of infection with extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Mexican hospital. J Clin Microbiol 2001, 39:3193-3196.
13. Fierer J., Guiney D. Extended-spectrum β-lactamases: a plague of plasmids. JAMA 1999, 281:563-564.
14. Performance standard for antimicrobial susceptibility testing. Document M100-S18. 2008 2008, Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute, Wayne, PA.
15. Kaufmann M.E. Pulse-field gel electrophoresis. Methods Mol Med 1998, 15:17-31.
16. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
17. Matthew M. Plasmid-mediated β-lactamases of Gram-negative bacteria: properties and distribution. J Antimicrob Chemother 1979, 5:349-358.
18. Silva-Sanchez J., Aguilar-Zacarias C. β-Lactamase bioassay: a simplified method to determine extended-spectrum β-lactamases (ESBL) in enterobacteria. Arch Med Res 1997, 28:285-287.
19. Espinal P., Garza-Ramos U., Reyna F., et al. Identification of SHV-type and CTX-M-12 extended-spectrum β-lactamases (ESBLs) in multiresistant Enterobacteriaceae from Colombian Caribbean hospitals. J Chemother 2010, 22:160-164.
20. Prodinger W.M., Fille M., Bauernfeind A., et al. Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 β-lactamase: parallel outbreaks due to multiple plasmid transfer. J Clin Microbiol 1996, 34:564-568.
21. Garza-Ramos U., Davila G., Gonzalez V., et al. The blaSHV-5 gene is encoded in a compound transposon duplicated in tandem in Enterobacter cloacae. Clin Microbiol Infect 2009, 15:878-880.
22. Kieser T. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 1984, 12:19-36.
23. Miller J. Experiments in Molecular Genetics 1972, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
24. Ishii Y., Ohno A., Taguchi H., et al. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A β-lactamase isolated from Escherichia coli. Antimicrob Agents Chemother 1995, 39:2269-2275.
25. Poole K. Efflux pumps as antimicrobial resistance mechanisms. Ann Med 2007, 39:162-176.
26. Mosqueda-Gomez J.L., Montano-Loza A., Rolon A.L., et al. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae A case-control study. Int J Infect Dis 2008, 12:653-659.
27. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004, 48:1-14.
28. Queenan A.M., Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007, 20:440-458.
29. Robicsek A., Jacoby G.A., Hooper D.C. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 2006, 6:629-640.